ASRS (Adult ADHD Self-Report Scale): A Complete Guide to This Clinical Screening Tool

The Adult ADHD Self-Report Scale (ASRS) is a structured self-report screening instrument developed in collaboration with the World Health Organization (WHO) and a team of leading ADHD researchers, including Ronald Kessler, Lenard Adler, and Thomas Spencer. It was designed to help identify adults who may exhibit patterns consistent with Attention-Deficit/Hyperactivity Disorder (ADHD) as defined by the DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision).

The ASRS is not a diagnostic tool. It functions as a screener — a first step that helps clinicians determine whether a more comprehensive evaluation for ADHD is warranted. This distinction is critical: a high score on the ASRS does not mean a person has ADHD, and a low score does not definitively rule it out. Rather, the tool identifies symptom patterns that align with the clinical presentation of adult ADHD and flags individuals who would benefit from further assessment.

The scale is one of the most widely used adult ADHD screening instruments in both clinical and research settings worldwide. Its development was grounded in the WHO's Composite International Diagnostic Interview (CIDI) and has been translated into numerous languages, making it one of the most globally accessible ADHD screening tools available.

The ASRS measures the frequency and severity of symptoms associated with adult ADHD, organized around the two core symptom domains defined in the DSM-5-TR:

• Inattention: Difficulty sustaining attention, trouble organizing tasks, forgetfulness in daily activities, being easily distracted, and frequently losing things necessary for tasks.
• Hyperactivity-Impulsivity: Feelings of restlessness, difficulty remaining seated, excessive talking, difficulty waiting one's turn, and acting without thinking through consequences.

The full ASRS (version 1.1) contains 18 items that correspond directly to the 18 DSM-IV-TR (and largely aligned with DSM-5-TR) diagnostic criteria for ADHD, adapted for adult presentation. Each item asks respondents to rate how often they have experienced a particular symptom over the past six months using a five-point Likert scale: Never, Rarely, Sometimes, Often, and Very Often.

An important design feature of the ASRS is that it reframes childhood-centric symptom descriptions into language relevant to adult life. For example, rather than asking about running and climbing inappropriately (a criterion more applicable to children), the ASRS asks about feelings of inner restlessness or difficulty staying seated during meetings — experiences more characteristic of how hyperactivity presents in adulthood.

The updated ASRS-5 (sometimes called ASRS v1.1 with DSM-5 alignment) has been revised to better reflect the DSM-5-TR criteria, which lowered the symptom threshold for adults from six to five symptoms in either domain and changed the age-of-onset criterion from before age 7 to before age 12.

The ASRS was developed specifically for adults aged 18 and older who may be experiencing symptoms consistent with ADHD. It is intended for use in several contexts:

• Primary care settings: General practitioners and family physicians frequently use the ASRS as a rapid screening tool during routine visits when patients report difficulties with concentration, organization, or impulsivity.
• Mental health clinics: Psychologists, psychiatrists, and clinical social workers use the ASRS as part of an intake assessment battery or when considering differential diagnoses.
• Occupational and educational settings: Some workplace or university disability services use the ASRS to identify individuals who may benefit from accommodations, though a full diagnostic evaluation is always required before accommodations are granted.
• Research: The ASRS is widely used in epidemiological studies to estimate ADHD prevalence in adult populations and in clinical trials to screen potential participants.

The tool is not validated for children or adolescents. Pediatric ADHD assessment relies on different instruments, such as the Conners Rating Scales or the Vanderbilt Assessment Scales, which incorporate parent and teacher observations critical for childhood diagnosis.

It is also important to note that the ASRS is most useful when administered to individuals who have not yet received an ADHD diagnosis. For individuals already diagnosed, clinicians typically use symptom monitoring scales or functional outcome measures rather than rescreening tools.

The ASRS is a self-administered questionnaire, meaning the individual completes it independently without clinician guidance. This makes it efficient and practical in high-volume clinical settings. The full 18-item version takes approximately 3 to 5 minutes to complete.

There are two primary versions used in practice:

• ASRS-v1.1 Screener (Part A — 6 items): This abbreviated version contains the six items found to be most predictive of an ADHD diagnosis. It was developed through logistic regression analysis to identify the subset of questions that best discriminated between individuals with and without ADHD. This 6-item screener is often used in primary care or time-limited settings where rapid screening is prioritized.
• ASRS-v1.1 Full Scale (Parts A + B — 18 items): The complete instrument includes all 18 symptom items. Part B (the remaining 12 items) provides additional clinical information about symptom frequency and can help characterize the breadth of ADHD-related difficulties a person is experiencing.

The ASRS is typically administered on paper, though digital versions are increasingly available through electronic health record systems and validated online platforms. Regardless of format, the instructions ask respondents to consider their experiences over the past six months and to answer based on how frequently each symptom occurs.

In clinical practice, the ASRS is often given at intake — either in the waiting room before an appointment or sent ahead of time as part of a pre-visit questionnaire packet. Clinicians then review the completed form and use the results to guide the clinical interview.

Scoring the ASRS depends on which version is being used and which scoring method is applied. There are two primary approaches:

1. Part A Screener Scoring (6-item version):

The 6-item screener uses a dichotomous shading system. Each item has a threshold marked by shading on the response form. If a response falls in the shaded area, that item is considered positive ("screened in"). The thresholds vary by item — for some questions, "Sometimes" is sufficient to screen positive, while for others, "Often" or "Very Often" is required. If four or more of the six items are endorsed at or above the threshold, the screening result is considered positive, and a comprehensive clinical evaluation is recommended.

2. Full Scale Symptom Scoring (18-item version):

The full ASRS can be scored by summing the frequency ratings across all 18 items, yielding a total score that reflects overall symptom burden. Scores range from 0 to 72, with higher scores indicating more frequent and pervasive symptoms. Some clinicians also examine subscale scores for inattention (items 1–9) and hyperactivity-impulsivity (items 10–18) separately to help characterize the symptom profile.

3. Updated ASRS-5 Scoring:

The more recently validated ASRS-5 scoring system, developed by Ustun and colleagues (2017), uses an optimized scoring algorithm that weights all 18 items and produces a total score ranging from 0 to 72. Research established a cutoff score of 14 or higher as the optimal threshold for identifying individuals likely to meet DSM-5 criteria for ADHD, balancing sensitivity and specificity.

Interpretation must always occur within a clinical context. A positive screen means the individual's reported symptoms are consistent with a pattern seen in adults with ADHD — it does not confirm a diagnosis. Factors such as substance use, mood disorders, sleep deprivation, anxiety, trauma history, and medical conditions can produce symptom presentations that overlap substantially with ADHD.

The ASRS has been evaluated extensively in psychometric research and demonstrates strong performance as a screening instrument:

Sensitivity and Specificity:

The original 6-item Part A screener demonstrated a sensitivity of 68.7% and a specificity of 99.5% in the initial validation study by Kessler and colleagues (2005), conducted using the National Comorbidity Survey Replication (NCS-R) dataset. This means it was highly effective at correctly identifying individuals who did not have ADHD (very few false positives), though it missed approximately one-third of true cases.

The updated ASRS-5 scoring system significantly improved diagnostic accuracy. Ustun et al. (2017) reported that the optimized 18-item scoring achieved a sensitivity of 91.4% and a specificity of 96.0%, with an overall classification accuracy (area under the ROC curve) of 0.94. This represents a substantial improvement over the original screener scoring method.

Internal Consistency:

The full 18-item ASRS consistently demonstrates good to excellent internal consistency, with Cronbach's alpha values typically ranging from 0.88 to 0.93 across studies. This indicates that the items reliably measure a coherent underlying construct.

Test-Retest Reliability:

Research has shown adequate test-retest reliability, suggesting that scores remain relatively stable over short intervals when the individual's clinical status has not changed.

Convergent Validity:

ASRS scores correlate significantly with other established measures of ADHD symptoms, clinician-rated assessments, and structured diagnostic interviews such as the Adult ADHD Clinical Diagnostic Scale (ACDS). This convergent validity supports the instrument's accuracy in measuring what it intends to measure.

Notably, most validation studies were conducted in general population or primary care samples. The tool's performance may differ in specialty psychiatric populations where comorbidity rates are high and symptom overlap between conditions is more pronounced.

Despite its strong psychometric properties and clinical utility, the ASRS has important limitations that clinicians and individuals should understand:

• It is a screener, not a diagnostic instrument. The ASRS cannot confirm or rule out ADHD. A comprehensive diagnostic evaluation requires a thorough clinical interview, developmental history, assessment of functional impairment across multiple domains, consideration of comorbid conditions, and collateral information from informants when possible.
• Self-report bias. The ASRS relies entirely on the individual's self-perception. Adults with ADHD may underestimate their symptoms due to poor self-awareness or long-standing compensatory strategies. On the other hand, individuals seeking a diagnosis (whether for accommodations, medication access, or validation) may overreport symptoms. There is no built-in validity scale to detect response bias.
• Symptom overlap with other conditions. Difficulty concentrating, restlessness, impulsivity, and disorganization are features of numerous psychiatric conditions, including major depressive disorder, generalized anxiety disorder, bipolar disorder, PTSD, substance use disorders, and personality disorders. The ASRS cannot differentiate between ADHD and these other conditions — it measures symptom frequency without establishing etiology.
• Limited developmental context. The DSM-5-TR requires that ADHD symptoms be present since childhood (before age 12). The ASRS assesses current symptom frequency over the past six months but does not systematically assess childhood symptom history. A positive screen in the absence of childhood symptoms may point toward a different diagnosis.
• Cultural and linguistic considerations. While the ASRS has been translated into many languages, cultural norms around attention, activity level, and self-reporting can influence how individuals respond. Validation in specific cultural populations is still an area of active research.
• Not sensitive to treatment effects. The ASRS was designed for screening, not for monitoring treatment response. Clinicians tracking symptom change over time during treatment may prefer instruments designed for that purpose, such as the ADHD Rating Scale-5 or the CGI (Clinical Global Impression) scale.

In clinical settings, the ASRS functions as one component within a broader assessment process. Here is how results are typically integrated:

Step 1: Screening. The ASRS is administered, often at intake or when ADHD is raised as a concern. A positive screen (4+ items on Part A or ≥14 on the ASRS-5 total score) prompts the clinician to pursue further evaluation.

Step 2: Comprehensive Diagnostic Interview. The clinician conducts a detailed clinical interview that explores the onset, duration, and context of symptoms. This includes gathering a developmental history to determine whether ADHD-like symptoms were present in childhood, consistent with DSM-5-TR's requirement that several symptoms be present before age 12.

Step 3: Differential Diagnosis. The clinician systematically considers alternative or co-occurring explanations for the reported symptoms. This may include screening for depression, anxiety, sleep disorders, substance use, thyroid dysfunction, and other medical or psychiatric conditions. Notably, adult ADHD has high comorbidity rates — research suggests that approximately 60–80% of adults with ADHD have at least one co-occurring psychiatric condition.

Step 4: Functional Impairment Assessment. A diagnosis of ADHD requires that symptoms cause clinically significant impairment in social, academic, or occupational functioning. The ASRS measures symptom frequency but does not directly assess impairment. Clinicians supplement the ASRS with questions about work performance, relationship difficulties, financial management, and daily functioning.

Step 5: Collateral Information. When possible, clinicians gather information from spouses, partners, family members, or old school records to corroborate self-reported symptoms and provide an external perspective on functional impairment.

Step 6: Integration and Diagnosis. Results from the ASRS, clinical interview, developmental history, collateral information, and differential diagnosis are synthesized. Only after this comprehensive process can a clinician make a formal ADHD diagnosis and develop an appropriate treatment plan.

The ASRS can also be useful in psychoeducation. Reviewing the completed screener with a patient can help illustrate how their specific difficulties map onto recognized symptom patterns, facilitating a collaborative discussion about next steps.

The ASRS is a freely available instrument. It is not proprietary, and there are no licensing fees for clinical or research use. This accessibility is one of its greatest strengths and a significant reason for its widespread adoption.

Reliable sources for accessing the ASRS include:

• World Health Organization (WHO): The ASRS was developed in conjunction with WHO and is available through their mental health assessment resources.
• Harvard Medical School/National Comorbidity Survey: The instrument and scoring instructions are available through resources associated with the NCS-R research project, led by Ronald Kessler's team at Harvard.
• ADHD clinical guidelines: Many professional organizations, including the American Academy of Family Physicians and the Canadian ADHD Resource Alliance (CADDRA), include the ASRS in their clinical toolkit recommendations.
• Published validation studies: The full instrument, including scoring instructions, has been published in peer-reviewed journals, most notably in the original Kessler et al. (2005) and Ustun et al. (2017) validation papers.

Individuals who complete the ASRS on their own should bring their results to a qualified healthcare provider for review. Self-administered screening results, without professional interpretation and follow-up assessment, cannot serve as the basis for diagnosis or treatment decisions.

Consider seeking a professional evaluation if you experience persistent, pervasive difficulties with attention, organization, impulsivity, or restlessness that:

• Have been present for at least six months and are not better explained by a recent stressor or life change
• Cause noticeable problems in two or more areas of life (work, relationships, daily self-management, finances)
• Began in childhood or adolescence, even if they were not recognized or addressed at the time
• Persist despite your best efforts to compensate with strategies, routines, or tools

A positive result on the ASRS is a strong reason to schedule an evaluation with a clinician experienced in adult ADHD assessment. This includes psychiatrists, clinical psychologists, neuropsychologists, and other licensed mental health professionals with training in ADHD.

If you are unsure where to start, a primary care physician can administer the ASRS, discuss your concerns, and provide a referral to a specialist for comprehensive evaluation. Many adults with ADHD are first identified in their 30s, 40s, or even later in life — it is never too late to seek answers and support.

This article is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.